AMNEAL PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Deferred Tax Assets, Operating Loss Carryforwards of $48.41 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $48.41M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.40M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $74.34M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $82.34M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $48.41M 10-K · filed 2026-02-27 |
| 2024-12-31 | $33.40M 10-K · filed 2026-02-27 |
| 2023-12-31 | $74.34M 10-K · filed 2025-02-28 |
| 2022-12-31 | $82.34M 10-K · filed 2024-03-14 |
| 2021-12-31 | $73.86M 10-K · filed 2023-03-03 |
| 2020-12-31 | $77.25M 10-K · filed 2022-03-01 |
| 2019-12-31 | $119.09M 10-K · filed 2021-03-01 |
| 2018-12-31 | $107.94M 10-K · filed 2020-03-02 |
| 2017-12-31 | $34.89M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |